Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
NCT04504526
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
Multiple Myeloma
Leukemia
Interventions
DRUG:
68Ga-Pentixafor
Sponsor
First Affiliated Hospital of Fujian Medical University